OptiNose Total Current Liabilities Over Time

OPTN Stock  USD 5.36  0.01  0.19%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out OptiNose Performance and OptiNose Correlation.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
  
As of the 16th of March 2025, Total Current Liabilities is likely to grow to about 213.2 M.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.35)
Revenue Per Share
8.3
Quarterly Revenue Growth
0.031
Return On Assets
(0.10)
Return On Equity
(10.51)
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Total Current Liabilities Analysis

Compare OptiNose and related stocks such as Collegium Pharmaceutical, Phibro Animal Health, and ANI Pharmaceuticals Total Current Liabilities Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
2010201120122013201420152016201720182019202020212022202320242025
COLL2.6 M2.6 M2.6 M2.6 M10.4 M5.8 M22.9 M31.5 M187.5 M197.3 M191.2 M230.4 M270.1 M457.9 M509.5 M535 M
PAHC69.9 M125.9 M115.4 M112.4 M111.3 M108.7 M115.8 M143.2 M154.2 M157.2 M164.1 M190.8 M176 M204.1 M234.8 M141.8 M
ANIP817.9 K7.2 M10.6 M3.5 M13.2 M11.8 M31.9 M39.2 M165.5 M61.7 M78.6 M87.5 M99.4 M145.5 M193.7 M203.4 M
PROC248.5 M248.5 M248.5 M248.5 M248.5 M248.5 M248.5 M248.5 M248.5 M248.5 M239.6 M188 M368.4 M368.4 M423.6 M287.2 M
LFCR1.4 M66.7 M50.8 M48.4 M56.2 M56.5 M51.5 M88.4 M137.1 M164.4 M101.9 M79.2 M79.4 M38.9 M44.7 M55 M
KMDA9.1 M23 M29.2 M32.6 M30.9 M22.9 M27.2 M29.4 M23.6 M32.7 M25 M54.1 M75.7 M49.6 M49.4 M35.2 M
SHPH4.6 K4.6 K4.6 K4.6 K4.6 K4.6 K105.3 K593.8 K593.8 K2.1 M2.1 M2.2 M975.7 KM1.5 B1.6 B
CPIXM6.6 M8.1 M7.5 M13.7 M12.4 M14.8 M17.7 M27.8 M24.2 M25.7 M19.3 M28.6 M28 M31.6 T33.2 T
IRWD29.9 M65.1 M54.9 M41 M60.5 M76.5 M91.1 M66 M119.5 M40.9 M32.7 M161.7 M25.5 M276.1 M317.5 M333.4 M
AMPH60.1 M60.1 M60.1 M65.4 M62.6 M60 M60.6 M67.2 M106.8 M90 M112.2 M103.8 M94.9 M225.4 M173.8 M108.5 M
ALKS1.3 M89.2 M85.9 M100.9 M130.6 M236.2 M212 M291.1 M339.8 M391.1 M438.3 M471.3 M497.7 M520.2 M465.2 M488.5 M
EOLS48.1 M48.1 M48.1 M48.1 M48.1 M48.1 M63.3 M212.7 M5.3 M24.4 M180.2 M57.7 M46.5 M48.3 M63 M60 M
PBH14.5 M63.9 M96.7 M84.4 M99 M106.7 M162 M123.2 M127 M149.9 M122.1 M143.4 M160.7 M117 M134.6 M97.9 M
RGC304 M400.7 M387.5 M506.4 M477 M551.3 M510 M561.4 M2.1 M3.2 M4.3 M577.8 K606.9 K193.6 K174.2 K165.5 K
NBIX4.1 M47.1 M15.6 M11.7 M15.7 M25.7 M30.4 M54.4 M88.2 M565.3 M186.5 M245.8 M537.7 M654.8 M507.7 M533.1 M
ITCIMM2.8 M6.8 M10.6 M6.3 M10.5 M14.2 M36.3 M36.2 M36.9 M53.4 M83.2 M123.5 M205.7 M216 M
DVAX4.1 M27.2 M19 M16.2 M20.3 M28.8 M20 M18.6 M38 M53 M77.4 M556.4 M150.1 M62.2 M78.6 M59.4 M

OptiNose and related stocks such as Collegium Pharmaceutical, Phibro Animal Health, and ANI Pharmaceuticals Total Current Liabilities description

Total Current Liabilities is an item on OptiNose balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of OptiNose are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

My Equities

My Current Equities and Potential Positions

OptiNose
OPTN
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationPennsylvania; U.S.A
ExchangeNASDAQ Exchange
USD 5.36
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out OptiNose Performance and OptiNose Correlation.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
OptiNose technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of OptiNose technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of OptiNose trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...